Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About JDRF & our impact > About JDRF > Our strategy
JDRF’s vision is a world without type 1 diabetes. To achieve our mission of eradicating type 1 diabetes and its effects for people in the UK we:
Through our international JDRF network, our funding of UK researchers, our advocacy work with the NHS and the support we provide to people with type 1, we know that we can push new boundaries and generate unprecedented progress in the next few years to prevent, treat and ultimately find cures for type 1 diabetes.
We are proud of our international affiliation with JDRF in the US, Canada, Australia, Israel and the Netherlands and our integrated global research strategy that delivers on our mission. JDRF’s organisational focus is, and will continue to be, funding the best type 1 research in the world while catalysing research partnerships to grow investment and delivery in UK type 1 diabetes research.
Our second goal focuses on accelerating access to type 1 technologies and treatments, not just for the near future but also preparing the landscape for the new generation of personalised medicines, currently in research, that are on the treatment horizon.
Research institutions are increasingly looking to charities like JDRF to support them in involving people who live with conditions such as type 1 to help define and shape research priorities. The rise of technologies and emerging medicines in the treatment of type 1 means that the NHS will be reviewing how new treatments are used and funded to support better health outcomes and wellbeing for people with type 1.
Our third goal focuses on our commitment to support people with type 1 at every age and stage of life. We do this by providing trusted information and through a wide range of community events.
We are proud of our role in helping build a supportive community of people with type 1. We work in partnership with the NHS and many charity service providers; we recognise their skill and value and never replicate or deliver services where others are best placed to do so.
Finally, our strategy focuses on how we at JDRF can further excel in our operational practices, growing income, our skills and impact as the type 1 diabetes charity in the UK.
Download a copy of our strategy.
Read our latest impact report and find out more about the research we fund that will cure, treat and prevent type 1 diabetes and its complications. Our report includes supporter and researcher stories as well as a snapshot of the incredible advances that we have made possible.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.